Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer
Statin Therapy as a Protective Technique for Potential Cardiovascular Event Occurrences Among Breast Cancer Patients Undergoing Chemotherapy Treatment
Sponsor: National Cancer Institute (NCI)
Terminated
slow accrual
Other terminated trials from National Cancer Institute (NCI)
This PHASE1 trial investigates Cardiovascular Complications and Recurrent Breast Cancer and is currently terminated or withdrawn. National Cancer Institute (NCI) leads this study, which shows 9 recorded versions since 2010 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE1
-
Aug 2018 — Jan 2021 [monthly]
Terminated PHASE1
-
Jun 2018 — Aug 2018 [monthly]
Terminated PHASE1
▶ Show 4 earlier versions
-
Jul 2017 — Jun 2018 [monthly]
Terminated PHASE1
-
May 2017 — Jul 2017 [monthly]
Terminated PHASE1
-
Feb 2017 — May 2017 [monthly]
Terminated PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1
First recorded
Jan 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Cancer Institute (NCI)
- Wake Forest University Health Sciences
For direct contact, visit the study record on ClinicalTrials.gov .